1990 - 2016年195个国家和地区因酒精和药物使用所致的全球疾病负担:全球疾病负担研究2016的系统分析
The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
出版信息
Lancet Psychiatry. 2018 Dec;5(12):987-1012. doi: 10.1016/S2215-0366(18)30337-7. Epub 2018 Nov 1.
BACKGROUND
Alcohol and drug use can have negative consequences on the health, economy, productivity, and social aspects of communities. We aimed to use data from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2016 to calculate global and regional estimates of the prevalence of alcohol, amphetamine, cannabis, cocaine, and opioid dependence, and to estimate global disease burden attributable to alcohol and drug use between 1990 and 2016, and for 195 countries and territories within 21 regions, and within seven super-regions. We also aimed to examine the association between disease burden and Socio-demographic Index (SDI) quintiles.
METHODS
We searched PubMed, EMBASE, and PsycINFO databases for original epidemiological studies on alcohol and drug use published between Jan 1, 1980, and Sept 7, 2016, with out language restrictions, and used DisMod-MR 2.1, a Bayesian meta-regression tool, to estimate population-level prevalence of substance use disorders. We combined these estimates with disability weights to calculate years of life lived with disability (YLDs), years of life lost (YLLs), and disability-adjusted life-years (DALYs) for 1990-2016. We also used a comparative assessment approach to estimate burden attributable to alcohol and drug use as risk factors for other health outcomes.
FINDINGS
Globally, alcohol use disorders were the most prevalent of all substance use disorders, with 100·4 million estimated cases in 2016 (age-standardised prevalence 1320·8 cases per 100 000 people, 95% uncertainty interval [95% UI] 1181·2-1468·0). The most common drug use disorders were cannabis dependence (22·1 million cases; age-standardised prevalence 289·7 cases per 100 000 people, 95% UI 248·9-339·1) and opioid dependence (26·8 million cases; age-standardised prevalence 353·0 cases per 100 000 people, 309·9-405·9). Globally, in 2016, 99·2 million DALYs (95% UI 88·3-111·2) and 4·2% of all DALYs (3·7-4·6) were attributable to alcohol use, and 31·8 million DALYs (27·4-36·6) and 1·3% of all DALYs (1·2-1·5) were attributable to drug use as a risk factor. The burden of disease attributable to alcohol and drug use varied substantially across geographical locations, and much of this burden was due to the effect of substance use on other health outcomes. Contrasting patterns were observed for the association between total alcohol and drug-attributable burden and SDI: alcohol-attributable burden was highest in countries with a low SDI and middle-high middle SDI, whereas the burden due to drugs increased with higher S DI level.
INTERPRETATION
Alcohol and drug use are important contributors to global disease burden. Effective interventions should be scaled up to prevent and reduce substance use disease burden.
FUNDING
Bill & Melinda Gates Foundation and Australian National Health and Medical Research Council.
背景
酒精和药物使用会对社区的健康、经济、生产力及社会层面产生负面影响。我们旨在利用2016年全球疾病、伤害及风险因素负担研究(GBD)的数据,计算全球及各区域酒精、苯丙胺、大麻、可卡因和阿片类物质依赖患病率的估计值,并估算1990年至2016年期间以及21个区域内、7个超级区域内195个国家和地区因酒精和药物使用导致的全球疾病负担。我们还旨在研究疾病负担与社会人口指数(SDI)五分位数之间的关联。
方法
我们检索了PubMed、EMBASE和PsycINFO数据库,查找1980年1月1日至2016年9月7日期间发表的关于酒精和药物使用的原始流行病学研究,无语言限制,并使用贝叶斯元回归工具DisMod-MR 2.1估算物质使用障碍的人群水平患病率。我们将这些估计值与残疾权重相结合,计算1990 - 2016年期间的残疾生活年数(YLDs)、生命损失年数(YLLs)和残疾调整生命年数(DALYs)。我们还采用比较评估方法估算因酒精和药物使用作为其他健康结果的风险因素所致的负担。
结果
在全球范围内,酒精使用障碍是所有物质使用障碍中最普遍的,2016年估计病例数为1.004亿(年龄标准化患病率为每10万人1320.8例,95%不确定区间[95% UI]为1181.2 - 1468.0)。最常见的药物使用障碍是大麻依赖(2210万例;年龄标准化患病率为每10万人289.7例,95% UI为248.9 - 339.1)和阿片类物质依赖(2680万例;年龄标准化患病率为每10万人353.0例,309.9 - 405.9)。在全球范围内,2016年,9920万DALYs(95% UI为8830 - 11120)以及所有DALYs的4.2%(3.7% - 4.6%)归因于酒精使用,3180万DALYs(2740 - 3660)以及所有DALYs的1.3%(1.2% - 1.5%)归因于作为风险因素的药物使用。因酒精和药物使用导致的疾病负担在不同地理位置差异很大,且这种负担大部分是由于物质使用对其他健康结果的影响。在酒精和药物所致总负担与SDI之间的关联方面观察到了不同模式:酒精所致负担在SDI低和中高SDI的国家最高,而药物所致负担随着SDI水平升高而增加。
解读
酒精和药物使用是全球疾病负担的重要促成因素。应扩大有效的干预措施以预防和减轻物质使用疾病负担。
资金来源
比尔及梅琳达·盖茨基金会和澳大利亚国家卫生与医学研究委员会。